ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice.

Takashi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.